Actively Recruiting

All Genders
NCT03503149

Molecular Tumor Board at the Center for Personalized Medicine Tübingen

Led by University Hospital Tuebingen · Updated on 2018-04-19

1000

Participants Needed

1

Research Sites

521 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Molecular Tumor Board at the Center for Personalized Medicine

CONDITIONS

Official Title

Molecular Tumor Board at the Center for Personalized Medicine Tübingen

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Given informed consent ("broad consent" of the University Hospital Tübingen)
  • 18 years of age or older
  • Clinical indication for referral to the Molecular Tumor Board by the treating physician
Not Eligible

You will not qualify if you...

  • Patients without cancer diagnosis, as the Molecular Tumor Board only assists cancer patients

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Hospital Tübingen

Tübingen, Baden-Wurttemberg, Germany, 72076

Actively Recruiting

Loading map...

Research Team

G

Ghazaleh Tabatabai, Prof

CONTACT

N

Nisar P Malek, Prof

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here